Details

New inhibitors of β-1,4-galactosyltransferase I discovered by virtual screening
ID Kranjc, Jaka (Author), ID Tomašič, Tihomir (Author), ID Pajk, Stane (Author), ID Brinc, Matjaž (Author), ID Pišlar, Anja (Author), ID Anderluh, Marko (Author)

.pdfPDF - Presentation file, Download (1,11 MB)
MD5: 0696283F1B4299FB4E8114BFF001F422
URLURL - Source URL, Visit https://chemistry-europe.onlinelibrary.wiley.com/doi/10.1002/cmdc.202400896 This link opens in a new window

Abstract
Seven different enzymes comprise the galactosyltransferases family, of which β-1,4-galactosyltransferase I (β-1,4-GALT1) is the major contributor to galactosylation activity in cells. Since abnormalities in galactosylation are associated with many pathophysiological conditions, β-1,4-GALT1 is an interesting new target for drug discovery and molecular probe design. There are several known β-1,4-GALT1 inhibitors, but most of them suffer from low cell permeability and thus low in vivo activity. In the present work, we describe an in silico screening performed using commercially available virtual compound libraries that led us to the discovery of novel β-1,4-GALT1 inhibitors. A virtual screening campaign was performed by docking compound libraries to the binding site of β-1,4-GALT1, followed by biological evaluation of selected hits for their β-1,4-GALT1 inhibitory activity. The IC$_{50}$ values were determined for the best performing inhibitors to obtain new chemotypes of β-1,4-GALT1 inhibitors.

Language:English
Keywords:β-1, 4-GALT1 inhibitors, galactosylation, β-1, 4-galactosyltransferase I, enzyme inhibitor, galactosyltransferase, UDP-Glo assay, virtual screening
Work type:Article
Typology:1.01 - Original Scientific Article
Organization:FFA - Faculty of Pharmacy
Publication status:Published
Publication version:Version of Record
Year:2025
Number of pages:6 str.
Numbering:Vol. 20, iss. 7, art. e202400896
PID:20.500.12556/RUL-168197 This link opens in a new window
UDC:615.4:54
ISSN on article:1860-7187
DOI:10.1002/cmdc.202400896 This link opens in a new window
COBISS.SI-ID:223097859 This link opens in a new window
Publication date in RUL:02.04.2025
Views:409
Downloads:109
Metadata:XML DC-XML DC-RDF
:
Copy citation
Share:Bookmark and Share

Record is a part of a journal

Title:ChemMedChem
Shortened title:ChemMedChem
Publisher:Wiley, Chemistry Europe
ISSN:1860-7187
COBISS.SI-ID:519053337 This link opens in a new window

Licences

License:CC BY-NC-ND 4.0, Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International
Link:http://creativecommons.org/licenses/by-nc-nd/4.0/
Description:The most restrictive Creative Commons license. This only allows people to download and share the work for no commercial gain and for no other purposes.

Secondary language

Language:Slovenian
Keywords:galaktoziltransferaza, galaktozilacija, zaviralci β-1, 4-GALT1, farmacevtska kemija

Projects

Funder:ARRS - Slovenian Research Agency
Project number:P1-0208
Name:Farmacevtska kemija: načrtovanje, sinteza in vrednotenje učinkovin

Funder:ARRS - Slovenian Research Agency
Project number:P4-0127
Name:Farmacevtska biotehnologija: znanost za zdravje

Funder:Novartis Pharmaceutical Manufacturing LLC

Similar documents

Similar works from RUL:
Similar works from other Slovenian collections:

Back